查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1535296

下一代定序（NGS）市場：依產品供應、應用和最終用戶劃分的產業展望，到2031年的全球預測

Next-Generation Sequencing (NGS) Market: Industry Outlook by Offering (Sample Preparation, Systems, Bioinformatics, Sequencing Services) Application (Clinical, Research) End User - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 451 Pages | 訂單完成後即時交付

價格

預計到2031年，全球次世代定序（NGS）市場將達到 427億美元，2024年至2031年的年複合成長率為 15.7%。

經過廣泛的二次和初步研究以及對市場情景的詳細分析，本報告由關鍵行業驅動因素、限制因素、挑戰和機會分析構成。

NGS 市場的成長是由於癌症發生率上升、NGS 在癌症治療和研究中的應用不斷增加、NGS 服務提供者與製藥公司之間的聯盟、NGS 技術進步、最佳化和簡化NGS 對工作流程的需求不斷增加、基因組定序的成本下降、定序程序的技術進步、NGS 資訊學解決方案的技術進步、藥品研發費增加、基因組作圖計劃的激增以及基於NGS 的診斷測試的監管和償付方案而推動的。

此外，NGS 的應用不斷增加，生物資訊學和基因組資料管理解決方案的採用不斷增加，供應商之間在開發樣本庫製備方案方面的合作，以及用於大規模資料分析和解釋的生物資訊學和基因組資料管理解決方案的使用不斷增加，醫院和臨床實驗室更加採用 NGS 資訊學工具，政府支持大規模基因組定序計畫的舉措。預計將為 NGS 市場中的公司創造成長機會。

本報告基於對四年期間（2021-2024年）行業主要市場參與者所提供的產品組合、區域格局和關鍵戰略發展的廣泛評估，提供了競爭格局。全球次世代定序（NGS）市場的主要公司包括 Illumina, Inc.（美國）、Thermo Fisher Scientific Inc.（美國）、F. Hoffmann-La Roche Ltd.（瑞士）、Revvity, Inc.（瑞士）、Revvity, Inc.（美國）、QIAGEN N.V.（荷蘭）、Agilent Technologies, Inc.（美國）、Pacific Biosciences of California, Inc.（美國）、Danaher Corporation（美國）、Oxford Nanopore Technologies Plc.（英國）、MGI Tech Co.Ltd.（中國）、Tecan Group Ltd.（瑞士）、Beijing Genomics Co.（瑞士）、Beijing Genomics Institute（BGI）（中國）、Eppendorf AG（德國）、Hamilton Company（美國）、Hudson Robotics（美國）、LGC Limited（英國）、Fabric Genomics, Inc.（美國）、DNASTAR, Inc.（美國）、Eurofins Scientific SE（盧森堡）、Novogene Co.Ltd.（中國）、Novogene Co.Ltd.（中國）、Quest Diagnostics Incorporated（美國）。

在本報告調查的產品中，商業定序/外包服務領域預計將在2024年佔據最大的市場佔有率，達到 38.0%。此細分市場的龐大市佔率歸因於 NGS 服務供應商提供的優勢，例如快速結果、成本效益以及適用於各種應用的廣泛服務。

在本報告調查的應用中，研究和其他應用領域預計將在2024年佔據次世代定序（NGS）市場的最大佔有率，達到 62.2%。該細分市場的很大一部分是由測序程序成本下降、製藥和生物技術公司在藥物發現方面的研究力度加大、NGS 在多種臨床和研究環境中的應用不斷增加、藥理學靶點發現推動的，這是由於使用量不斷增加資訊學解決方案，以確認治療假設並預測針對分子標靶的抑制化合物的潛在安全性。

在本報告調查的最終用戶中，製藥和生物技術領域預計將在2024年佔據下一代定序（NGS）市場的最大佔有率，達到 43.5%。該細分市場的巨大市場佔有率歸因於製藥和生物技術公司研發支出的增加以及慢性病盛行率的上升，這推動製藥和生物技術公司採用下一代定序產品成為可能。

對全球次世代定序（NGS）市場區域狀況的詳細分析提供了五個關鍵區域（北美、歐洲、亞太地區、拉丁美洲、中東和非洲）的詳細定性和定量見解，以及每個地區的一系列主要國家。估計到2024年，北美將佔據次世代定序（NGS）市場的最大佔有率，超過 48.7%。此外，估計到2024年，美國將佔據北美下一代定序（NGS）市場的最大佔有率。北美市場佔有率較大的原因是政府在基因組研究方面的積極舉措、基於序列的研究的應用不斷成長、該地區下一代測序技術主要提供者的存在以及製藥企業和生物製藥公司增加的研究投資，減少了定序成本加上先進定序產品和解決方案的可用性不斷增加，以及癌症發生率的增加，這是由於該地區的贖回情況良好。

調查範圍：

次世代定序（NGS）市場評估：依產品分類

  • 樣品製備
    • 試劑盒和試劑
  • 核酸萃取與擴增
  • 樣品庫準備
  • DNA樣品庫製備
  • RNA樣品庫製備
  • 品質控制
  • 其他試劑（1）
    • 用於樣品庫製備的工作站/機器人平台
  • 序列
    • NGS系統
  • 依成分排列的順序
  • 離子半導體序列
  • 單分子即時定序（SMRT）
  • DNA 奈米球（DNB）序列
  • 其他技術（2）
    • 服務（3）
  • 資料分析/生物資訊學
    • 軟體
  • 依類型
  • 資料分析軟體
  • 資料解讀與報告工具
  • 資料儲存/運算工具
  • 實驗室資訊管理系統（LIMS）
  • 依部署類型
  • 基於網路和雲端的
  • 本地
    • NGS 資訊學服務（4）
  • 商業序列/外包服務
    • 目標序列服務
    • RNA定序服務
    • 全基因組定序服務
    • 從頭定序服務
    • 外顯子定序服務
    • ChIP 定序服務
    • 甲基定序服務
    • 其他商業定序服務（5）

次世代定序（NGS）市場評估：依應用分類

  • 研究和其他用途
    • 藥物發現
    • 農業/動物研究
    • 其他用途（6）
  • 臨床應用
    • 生殖醫學診斷
    • 腫瘤學
    • 傳染病
    • 其他臨床用途（7）

次世代定序（NGS）市場評估：依最終用戶劃分

  • 醫院/診斷實驗室
  • 製藥和生技公司
  • 學術機構/研究中心
  • 其他最終用戶（8）

註：1.其他試劑包括稀釋緩衝液、DNA 標準品、標靶富集試劑盒/試劑、其他支持 NGS 樣品製備工作流程所需的試劑。

2.其他技術包括Nanopore定序和Avidity定序技術。

3.服務包括軟體升級、客戶支援、設備訓練、監控與安裝服務等支援服務。

4.NGS資訊學服務包括生物資訊學資料分析服務、生物資訊學諮詢服務、生物資訊學培訓、IT專業服務等支援服務。

5.其他商業定序服務包括降解圓頂定序、核醣體分析、擴增子定序、CRISPR 驗證、病毒基因組定序和免疫基因體學服務。

6.其他應用包括食品微生物學、食品和飲料行業的微生物組分析以及環境研究。

7.其他臨床應用包括檢測神經系統疾病、罕見疾病、代謝和免疫疾病以及食源性疾病的遺傳異常。

8.其他最終用戶包括法醫實驗室、安全機構、食品和飲料公司、農業公司。

次世代定序（NGS）市場評估：依最終用戶劃分

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 西班牙
    • 其他歐洲（RoE）
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他亞太地區（RoAPAC）
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 中東、非洲

目錄

第1章 簡介

第2章 研究方法

第3章 執行摘要

第4章 市場洞察

  • 市場
  • 摘要
  • 影響市場成長的因素
    • 市場動態影響分析
      • 癌症發生率上升以及 NGS 在癌症治療和研究中的應用不斷增加推動市場成長
      • 替代技術的可用性限制了市場成長
      • NGS 在個人化醫療中的應用擴展為市場公司創造了成長機會
      • 對資料儲存、處理、解釋和保密性的擔憂可能仍然是市場利益相關者面臨的關鍵問題
    • 因素分析
  • 產業趨勢
    • 透過加強 NGS 解決方案提供者之間的合作夥伴關係和協作，擴大和推進產品供應
    • 攜帶式定序技術的發展
    • 對 NGS 自動化的需求不斷增加
  • 價格分析
    • NGS 設備和耗材
    • NGS 服務
  • 監理分析
    • NGS 設備和耗材
      • 北美
        • 美國
        • 加拿大
      • 歐洲
      • 亞太地區
        • 中國
        • 日本
        • 印度
      • 拉丁美洲
      • 中東
    • NGS資訊學
  • 案例研究/使用範例
    • 案例研究 A
    • 案例研究 B
    • 個案研究 C
    • 案例研究 D
  • 波特五力分析

第5章 次世代定序（NGS）市場評估：依產品分類

  • 摘要
  • 樣品製備
    • 試劑盒和試劑
      • 核酸萃取與擴增
      • 樣品庫準備
        • DNA樣品庫製備
        • RNA樣品庫製備
      • 品質控制
      • 其他試劑盒和試劑
    • NGS工作站
  • 序列
    • NGS系統
      • 依成分排列的順序
      • 離子半導體序列
      • 單分子即時定序（SMRT）
      • DNA 奈米球（DNB）序列
      • 其他技術
    • 消耗品
    • 服務
  • 資料分析/生物資訊學
    • 軟體
      • 軟體市場，依類型
        • 資料分析軟體
        • 資料解讀與報告工具
        • 資料儲存與運算工具
        • 實驗室資訊管理系統（LIMS）
      • 軟體市場：依部署模式
        • 基於網路和雲端的
        • 本地
    • NGS資訊學服務
  • 商業序列/外包服務
    • 目標序列服務
    • RNA定序服務
    • 從頭定序服務
    • 外顯子定序服務
    • 晶片序列服務
    • 甲基定序服務
    • 全基因組定序服務
    • 其他商業定序服務

第6章 次世代定序（NGS）市場評估：依應用分類

  • 摘要
  • 研究和其他用途
    • 藥物發現
    • 農業與動物研究
    • 其他用途
  • 臨床應用
    • 腫瘤學
    • 生殖醫學
    • 傳染病
    • 其他臨床應用

第7章 次世代定序（NGS）市場評估：依最終使用者

  • 摘要
  • 製藥和生技公司
  • 醫院和診斷實驗室
  • 學術機構與研究中心
  • 其他最終用戶

第8章 次世代定序（NGS）市場評估：依地區

  • 摘要
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他歐洲（RoE）
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區（RoAPAC）
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲（RoLATAM）
  • 中東、非洲

第9章 競爭分析

  • 摘要
  • 主要成長策略
  • 競爭基準測試
  • 競爭對手儀表板
    • 行業領導者
    • 市場差異化因素
    • 領先企業
    • 新興公司
  • 市佔率分析（2023年）
    • 儀器和消耗品
    • 資料分析/生物資訊學
    • 商業定序/外包服務
    • NGS 工作站

第10章 公司簡介（公司概況、財務概況、產品組合、策略發展）

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Eurofins Scientific Se
  • Beijing Genomics Institute（BGI）
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Revvity, Inc.
  • Pacific Biosciences of California Inc.
  • Danaher Corporation
  • Oxford Nanopore Technologies Plc.
  • Tecan Group Ltd.
  • Hamilton Company
  • Hudson Robotics
  • LGC Limited
  • Eppendorf AG
  • Novogene Co., Ltd.
  • Dnastar, Inc.
  • Fabric Genomics, Inc.
  • MGI Tech Co., Ltd.
  • Quest Diagnostics Incorporated

（*註：為前 5 名公司提供 SWOT 分析*）

第11章 附錄

Product Code: MRHC - 1041274

Next-Generation Sequencing (NGS) Market: Industry Outlook by Offering (Sample Preparation [DNA Extraction, Library Preparation, Automation], Systems, Bioinformatics, Sequencing Services) Application (Clinical, Research) End User-Global Forecast to 2031

The global next-generation sequencing (NGS) market is projected to reach $42.7 billion by 2031 at a CAGR of 15.7% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities.

The growth of the NGS market is driven by the rising cancer prevalence & the increasing application of NGS in cancer treatment and research, partnerships between NGS service providers & pharmaceutical companies, technological advancements in NGS, the growing demand for optimized & streamlined NGS workflows, the declining costs of genome sequencing, technological advancements in sequencing procedures, technological advancements in NGS informatics solutions, increasing pharmaceutical R&D expenditures, the surge in genome mapping programs, and improvements in regulatory & reimbursement scenarios for NGS-based diagnostic tests.

Furthermore, the increasing applications of NGS, the rising adoption of bioinformatics and genomic data management solutions, collaborations between vendors to develop library preparation protocols, the growing use of bioinformatics and genomic data management solutions for large-scale data analysis and interpretation, the increasing adoption of NGS informatics tools among hospitals and clinical laboratories, and government initiatives supporting large-scale genomic sequencing projects are expected to generate growth opportunities for the players operating in the NGS market.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the global next-generation sequencing (NGS) market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Oxford Nanopore Technologies Plc. (U.K.), MGI Tech Co., Ltd. (China), Tecan Group Ltd. (Switzerland), Beijing Genomics Institute (BGI) (China), Eppendorf AG (Germany), Hamilton Company (U.S.), Hudson Robotics (U.S.), LGC Limited (U.K.), Fabric Genomics, Inc. (U.S.), DNASTAR, Inc. (U.S.), Eurofins Scientific SE (Luxembourg), Novogene Co. Ltd. (China), and Quest Diagnostics Incorporated (U.S.).

Among the offerings studied in this report, in 2024, the commercial sequencing/outsourced services segment is expected to account for the largest share of 38.0% of the market. The large market share of this segment can be attributed to the benefits offered by NGS service providers, including quick results, cost-effectiveness, and a wide array of services available for various applications.

Among the applications studied in this report, in 2024, the research & other applications segment is expected to account for the largest share of 62.2% of the next-generation sequencing (NGS) market. The large share of the segment is attributed to the decreasing cost of sequencing procedures, increasing R&D by pharmaceutical and biotechnology companies for drug discovery, the increasing applications of NGS in multiple clinical and research settings, and the increasing use of informatics solutions to find pharmacological targets, confirm therapeutic hypotheses, and predict the potential safety of inhibitory compounds aimed at molecular targets.

Among the end users studied in this report, in 2024, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of 43.5% of the next-generation sequencing (NGS) market. The large market share of this segment can be attributed to the increasing R&D spending by pharmaceutical & biotechnology companies and the rising incidence of chronic diseases, which drive the adoption of next-generation sequencing products among pharmaceutical & biotechnology companies.

An in-depth analysis of the geographical scenario of the global next-generation sequencing (NGS) market provides detailed qualitative and quantitative insights into five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of over 48.7% of the next-generation sequencing (NGS) market. Additionally, in 2024, the U.S. is expected to account for the largest share of the next-generation sequencing (NGS) market in North America. North America's large market share is attributed to the favorable government initiatives for genomic research, growing applications of sequencing-based research, presence of leading providers of next-generation sequencing technologies in the region, increasing research investments by pharmaceutical and biopharmaceutical companies, declining cost of sequencing coupled with the rising availability of advanced sequencing products and solutions, increasing cancer prevalence, and favorable reimbursement scenario in the region.

Scope of the Report:

Next-Generation Sequencing (NGS) Market Assessment-by Offering

  • Sample Preparation
    • Kits & Reagents
  • Nucleic Acid Extraction and Amplification
  • Library Preparation
  • DNA Library Preparation
  • RNA Library Preparation
  • Quality Control
  • Other Reagents (1)
    • Workstations/Robotic Platforms for Library Preparation
  • Sequencing
    • NGS Systems
  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-molecule Real-time Sequencing (SMRT)
  • DNA Nanoball (DNB) Sequencing
  • Other Technologies (2)
    • Services (3)
  • Data Analysis/Bioinformatics
    • Software
  • By Type
  • Data Analysis Software
  • Data Interpretation and Reporting Tools
  • Data Storage and Computing Tools
  • Laboratory Information Management Systems (LIMS)
  • By Deployment Mode
  • Web and Cloud-based
  • On-premise
    • NGS Informatics Services (4)
  • Commercial Sequencing/ Outsourced Services
    • Targeted Sequencing Services
    • RNA Sequencing Services
    • Whole Genome Sequencing Services
    • De Novo Sequencing Services
    • Exome Sequencing Services
    • ChIP Sequencing Services
    • Methyl Sequencing Services
    • Other Commercial Sequencing Services (5)

Next-Generation Sequencing (NGS) Market Assessment-by Application

  • Research & Other Applications
    • Drug Discovery
    • Agriculture & Animal Research
    • Other Applications (6)
  • Clinical Applications
    • Reproductive Health Diagnosis
    • Oncology
    • Infectious Diseases
    • Other Clinical Applications (7)

Next-Generation Sequencing (NGS) Market Assessment-by End User

  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic Institutes & Research Centers
  • Other End Users (8)

Note: 1. Other Reagents include dilution buffers, DNA standards, target enrichment kits/reagents, and other reagents required to support the NGS sample preparation workflow

2. Other Technologies include Nanopore sequencing & Avidity Sequencing Technology

3. Services include support services, such as the upgradation of software, customer support, equipment training, monitoring, installation services, and more

4. NGS informatics services include support services, such as bioinformatics data analysis services, bioinformatics consulting services, bioinformatics training, and IT professional services.

5. Other Commercial Sequencing Services include degradome sequencing, ribosome profiling, amplicon sequencing, CRISPR validation, viral genome sequencing, and immunogenomics services

6. Other Applications include food microbiology, microbiota analysis in the beverage industry, and environmental studies

7. Other Clinical Applications include detection of genetic aberrations in neurological disorders, rare diseases, metabolic and immune disorders, and food-borne illnesses

8. Other End Users include forensic laboratories & security agencies, food & beverage companies, and agriculture companies.

Next-Generation Sequencing (NGS) Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecasting
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Impact Analysis of Market Dynamics
      • 4.2.1.1. Rising Cancer Prevalence & Increasing Application of NGS in Cancer Treatment and Research Driving Market Growth
      • 4.2.1.2. Availability of Alternative Technologies Restraining Market Growth
      • 4.2.1.3. Increasing Application of NGS in Personalized Medicine Generating Growth Opportunities for Market Players
      • 4.2.1.4. Data Storage, Handling, Interpretation, and Confidentiality Concerns Expected to Remain a Major Challenge for Market Stakeholders
    • 4.2.2. Factor Analysis
  • 4.3. Industry Trends
    • 4.3.1. Increasing Partnerships & Collaborations Among NGS Solution Providers to Expand and Advance Product Offerings
    • 4.3.2. Development of Portable Sequencing Technologies
    • 4.3.3. Increasing Demand for NGS Automation
  • 4.4. Pricing Analysis
    • 4.4.1. NGS Instruments and Consumables
    • 4.4.2. NGS Services
  • 4.5. Regulatory Analysis
    • 4.5.1. NGS Instruments & Consumables
      • 4.5.1.1. North America
        • 4.5.1.1.1. U.S.
        • 4.5.1.1.2. Canada
      • 4.5.1.2. Europe
      • 4.5.1.3. Asia-Pacific
        • 4.5.1.3.1. China
        • 4.5.1.3.2. Japan
        • 4.5.1.3.3. India
      • 4.5.1.4. Latin America
      • 4.5.1.5. Middle East
    • 4.5.2. NGS Informatics
  • 4.6. Case Studies/Use Cases
    • 4.6.1. Case Study A
    • 4.6.2. Case Study B
    • 4.6.3. Case Study C
    • 4.6.4. Case Study D
  • 4.7. Porter's Five Forces Analysis
    • 4.7.1. Bargaining Power of Buyers
    • 4.7.2. Bargaining Power of Suppliers
    • 4.7.3. Threat of Substitutes
    • 4.7.4. Threat of New Entrants
    • 4.7.5. Degree of Competition

5. Next-Generation Sequencing (NGS) Market Assessment - by Offering

  • 5.1. Overview
  • 5.2. Sample Preparation
    • 5.2.1. Kits & Reagents
      • 5.2.1.1. Nucleic Acid Extraction and Amplification
      • 5.2.1.2. Library Preparation
        • 5.2.1.2.1. DNA Library Preparation
        • 5.2.1.2.2. RNA Library Preparation
      • 5.2.1.3. Quality Control
      • 5.2.1.4. Other Kits & Reagents
    • 5.2.2. NGS Workstations
  • 5.3. Sequencing
    • 5.3.1. NGS Systems
      • 5.3.1.1. Sequencing by Synthesis
      • 5.3.1.2. Ion Semiconductor Sequencing
      • 5.3.1.3. Single-Molecule Real-Time Sequencing (SMRT)
      • 5.3.1.4. DNA Nanoball (DNB) Sequencing
      • 5.3.1.5. Other Technologies
    • 5.3.2. Consumables
    • 5.3.3. Services
  • 5.4. Data Analysis/Bioinformatics
    • 5.4.1. Software
      • 5.4.1.1. Software Market, by Type
        • 5.4.1.1.1. Data Analysis Software
        • 5.4.1.1.2. Data Interpretation and Reporting Tools
        • 5.4.1.1.3. Data Storage and Computing Tools
        • 5.4.1.1.4. Laboratory Information Management Systems (LIMS)
      • 5.4.1.2. Software Market, by Deployment Mode
        • 5.4.1.2.1. Web and Cloud-Based
        • 5.4.1.2.2. On-Premise
    • 5.4.2. NGS Informatics Services
  • 5.5. Commercial Sequencing/Outsourced Services
    • 5.5.1. Targeted Sequencing Services
    • 5.5.2. RNA Sequencing Services
    • 5.5.3. De Novo Sequencing Services
    • 5.5.4. Exome Sequencing Services
    • 5.5.5. Chip Sequencing Services
    • 5.5.6. Methyl Sequencing Services
    • 5.5.7. Whole Genome Sequencing Services
    • 5.5.8. Other Commercial Sequencing Services

6. Next-Generation Sequencing (NGS) Market Assessment - by Application

  • 6.1. Overview
  • 6.2. Research & Other Applications
    • 6.2.1. Drug Discovery
    • 6.2.2. Agriculture & Animal Research
    • 6.2.3. Other Applications
  • 6.3. Clinical Applications
    • 6.3.1. Oncology
    • 6.3.2. Reproductive Health
    • 6.3.3. Infectious Diseases
    • 6.3.4. Other Clinical Applications

7. Next-Generation Sequencing (NGS) Market Assessment - by End User

  • 7.1. Overview
  • 7.2. Pharmaceutical & Biotechnology Companies
  • 7.3. Hospitals & Diagnostic Laboratories
  • 7.4. Academic Institutes & Research Centers
  • 7.5. Other End Users

8. Next-Generation Sequencing (NGS) Market Assessment - by Geography

  • 8.1. Overview
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Rest of Europe (RoE)
  • 8.4. Asia-Pacific
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. India
    • 8.4.4. Rest of Asia-Pacific (RoAPAC)
  • 8.5. Latin America
    • 8.5.1. Brazil
    • 8.5.2. Mexico
    • 8.5.3. Rest of Latin America (RoLATAM)
  • 8.6. Middle East & Africa

9. Competition Analysis

  • 9.1. Overview
  • 9.2. Key Growth Strategies
  • 9.3. Competitive Benchmarking
  • 9.4. Competitive Dashboard
    • 9.4.1. Industry Leaders
    • 9.4.2. Market Differentiators
    • 9.4.3. Vanguards
    • 9.4.4. Emerging Companies
  • 9.5. Market Share Analysis (2023)
    • 9.5.1. Instrument & Consumables
    • 9.5.2. Data Analysis/Bioinformatics
    • 9.5.3. Commercial Sequencing/Outsourced Services
    • 9.5.4. NGS Workstations

10. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)

  • 10.1. Illumina, Inc.
  • 10.2. Thermo Fisher Scientific Inc.
  • 10.3. F. Hoffmann-La Roche Ltd
  • 10.4. Eurofins Scientific Se
  • 10.5. Beijing Genomics Institute (BGI)
  • 10.6. Qiagen N.V.
  • 10.7. Agilent Technologies, Inc.
  • 10.8. Revvity, Inc.
  • 10.9. Pacific Biosciences of California Inc.
  • 10.10. Danaher Corporation
  • 10.11. Oxford Nanopore Technologies Plc.
  • 10.12. Tecan Group Ltd.
  • 10.13. Hamilton Company
  • 10.14. Hudson Robotics
  • 10.15. LGC Limited
  • 10.16. Eppendorf AG
  • 10.17. Novogene Co., Ltd.
  • 10.18. Dnastar, Inc.
  • 10.19. Fabric Genomics, Inc.
  • 10.20. MGI Tech Co., Ltd.
  • 10.21. Quest Diagnostics Incorporated

(*Note: SWOT Analysis Provided for Top 5 Companies*)

11. Appendix

  • 11.1. Available Customization
  • 11.2. Related Reports

LIST OF TABLES

  • Table 1 Global NGS Market: Impact Analysis of Market Dynamics (2024-2031)
  • Table 2 Global Estimated Number of New Cancer Cases, by Type (2020 Vs. 2030)
  • Table 3 Incidence of Common Genetic Disorders
  • Table 4 Major Genome Sequencing Projects, by Country
  • Table 5 Portable Sequencers Vs. Benchtop Sequencers
  • Table 6 NGS Instruments Price List
  • Table 7 NGS Consumables Price List
  • Table 8 Key NGS Service Providers' Price List
  • Table 9 Regulatory Authorities Governing In Vitro Diagnostics & NGS Products, by Country/Region
  • Table 10 NGS Software: Standards and Compliance Guidelines
  • Table 11 NGS Informatics: Standards and Compliance Guidelines
  • Table 12 Global NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 14 Global NGS Sample Preparation Market, by Country/Region, 2022-2031 (USD Million)
  • Table 15 Global NGS Sample Preparation Kits & Reagents Market, by Type, 2022-2031 USD Million)
  • Table 16 Global NGS Sample Preparation Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
  • Table 17 Global Nucleic Acid Extraction and Amplification Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
  • Table 18 Global Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 19 Global Library Preparation Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
  • Table 20 Global DNA Library Preparation Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
  • Table 21 Global RNA Library Preparation Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
  • Table 22 Global Quality Control Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
  • Table 23 Global Other Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
  • Table 24 Global NGS Workstations Market for NGS Library Preparation, by Country/Region, 2022-2031 (USD Million)
  • Table 25 Global Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 26 Global Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 27 Global NGS Systems Market, by Technology, 2022-2031 (USD Million)
  • Table 28 Global NGS Systems Market, by Country/Region, 2022-2031 (USD Million)
  • Table 29 Global Sequencing by Synthesis Systems Market, by Country/Region, 2022-2031 (USD Million)
  • Table 30 Major Applications of Ion Torrent Sequencing
  • Table 31 Global Ion Semi Conductor Sequencing Systems Market, by Country/Region, 2022-2031 (USD Million)
  • Table 32 Global Smrt Systems Market, by Country/Region, 2022-2031 (USD Million)
  • Table 33 Global DNA Nanoball Sequencing Systems Market, by Country/Region, 2022-2031 (USD Million)
  • Table 34 Global Other Technologies Market, by Country/Region, 2022-2031 (USD Million)
  • Table 35 Global Consumables Market, by Country/Region, 2022-2031 (USD Million)
  • Table 36 Global Services Market, by Country/Region, 2022-2031 (USD Million)
  • Table 37 Global Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 38 Global Data Analysis/Bioinformatics Market, by Country/Region, 2022-2031 (USD Million)
  • Table 39 Global Data Analysis/Bioinformatics Software Market, by Country/Region, 2022-2031 (USD Million)
  • Table 40 Global Data Analysis/Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 41 Global Data Analysis Software Market, by Country/Region, 2022-2031 (USD Million)
  • Table 42 Global Data Interpretation and Reporting Tools Market, by Country/Region, 2022-2031 (USD Million)
  • Table 43 Global Data Storage and Computing Tools Market, by Country/Region, 2022-2031 (USD Million)
  • Table 44 Global Laboratory Information Management Systems (LIMS) Market by Country/Region, 2022-2031 (USD Million)
  • Table 45 Global Data Analysis/Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 46 Global Web and Cloud-Based Data/Analysis and Bioinformatics Market by Country/Region, 2022-2031 (USD Million)
  • Table 47 Global On-Premise Data/Analysis and Bioinformatics Market by Country/Region, 2022-2031 (USD Million)
  • Table 48 Global NGS Informatics Services Market by Country/Region, 2022-2031 (USD Million)
  • Table 49 Global NGS Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 50 Global Commercial Sequencing/Outsourced Services Market by Country/Region, 2022-2031 (USD Million)
  • Table 51 Global Targeted Sequencing Services Market by Country/Region, 2022-2031 (USD Million)
  • Table 52 Global RNA Sequencing Services Market by Country/Region, 2022-2031 (USD Million)
  • Table 53 Global De Novo Sequencing Services Market by Country/Region, 2022-2031 (USD Million)
  • Table 54 Global Exome Sequencing Services Market by Country/Region, 2022-2031 (USD Million)
  • Table 55 Global Chip Sequencing Services Market by Country/Region, 2022-2031 (USD Million)
  • Table 56 Global Methylation Sequencing Services Market, by Country/Region, 2022-2031 (USD Million)
  • Table 57 Global Whole Genome Sequencing Services Market, by Country/Region, 2022-2031 (USD Million)
  • Table 58 Global Other Commercial Sequencing Services Market, by Country/Region, 2022-2031 (USD Million)
  • Table 59 Global Next-Generation Sequencing (NGS) Market, by Application, 2022-2031 (USD Million)
  • Table 60 Global NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 61 Global NGS Market for Research & Other Applications by Country/Region, 2022-2031 (USD Million)
  • Table 62 Global NGS Market for Drug Discovery, by Country/Region, 2022-2031 (USD Million)
  • Table 63 Global NGS Market for Agriculture & Animal Research, by Country/Region, 2022-2031 (USD Million)
  • Table 64 Global NGS Market for Other Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 65 Global NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 66 Global NGS Market for Clinical Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 67 Currently Available Targeted Therapies and Corresponding Biomarkers
  • Table 68 Global NGS Market for Oncology, by Country/Region, 2022-2031 (USD Million)
  • Table 69 Global NGS Market for Reproductive Health, by Country/Region, 2022-2031 (USD Million)
  • Table 70 Number of New HIV Infections, by Region, 2022
  • Table 71 Global NGS Market for Infectious Diseases, by Country/Region, 2022-2031 (USD Million)
  • Table 72 Global NGS Market for Other Clinical Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 73 Global Next-Generation Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 74 Pharmaceutical Spending in Major Countries
  • Table 75 Global Next-Generation Sequencing Market for Pharmaceutical & Biotechnology Companies, by Offering, 2022-2031 (USD Million)
  • Table 76 Global Next-Generation Sequencing Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022-2031 (USD Million)
  • Table 77 Global Next-Generation Sequencing Market for Hospitals & Diagnostic Laboratories, by Offering, 2022-2031 (USD Million)
  • Table 78 Global Next-Generation Sequencing Market for Hospitals & Diagnostic Laboratories, by Country/Region, 2022-2031 (USD Million)
  • Table 79 Global Next-Generation Sequencing Market for Academic Institutes & Research Centers, by Offering, 2022-2031 (USD Million)
  • Table 80 Global Next-Generation Sequencing Market for Academic Institutes & Research Centers, by Country/Region, 2022-2031 (USD Million)
  • Table 81 Global Next-Generation Sequencing Market for Other End Users, by Offering, 2022-2031 (USD Million)
  • Table 82 Global Next-Generation Sequencing Market for Other End Users, by Country/Region, 2022-2031 (USD Million)
  • Table 83 Global NGS Market, by Country/Region, 2022-2031 (USD Million)
  • Table 84 North America: NGS Market, by Country, 2022-2031 (USD Million)
  • Table 85 North America: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 86 North America: Sample Preparation Market, by Type, 2022-2031 (USD Million)
  • Table 87 North America: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 88 North America: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 89 North America: Sequencing Market, by Type, 2022-2031 (USD Million)
  • Table 90 North America: Sequencing Systems Market, by Technology, 2022-2031 (USD Million)
  • Table 91 North America: Data Analysis/Bioinformatics Market, by Type, 2022-2031 (USD Million)
  • Table 92 North America: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 93 North America: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 94 North America: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 95 North America: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 96 North America: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 97 North America: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 98 North America: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 99 U.S.: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 100 U.S.: Sample Preparation Market, by Type, 2022-2031 (USD Million)
  • Table 101 U.S.: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 102 U.S.: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 103 U.S.: Sequencing Market, by Type, 2022-2031 (USD Million)
  • Table 104 U.S.: Sequencing Systems Market, by Technology, 2022-2031 (USD Million)
  • Table 105 U.S.: Data Analysis/Bioinformatics Market, by Type, 2022-2031 (USD Million)
  • Table 106 U.S.: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 107 U.S.: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 108 U.S.: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 109 U.S.: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 110 U.S.: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 111 U.S.: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 112 U.S.: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 113 Canada: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 114 Canada: Sample Preparation Market, by Type, 2022-2031 (USD Million)
  • Table 115 Canada: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 116 Canada: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 117 Canada: Sequencing Market, by Type, 2022-2031 (USD Million)
  • Table 118 Canada: Sequencing Systems Market, by Technology, 2022-2031 (USD Million)
  • Table 119 Canada: Data Analysis/Bioinformatics Market, by Type, 2022-2031 (USD Million)
  • Table 120 Canada: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 121 Canada: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 122 Canada: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 123 Canada: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 124 Canada: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 125 Canada: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 126 Canada: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 127 Europe: NGS Market, by Country/Region, 2022-2031 (USD Million)
  • Table 128 Europe: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 129 Europe: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 130 Europe: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 131 Europe: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 132 Europe: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 133 Europe: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 134 Europe: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 135 Europe: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 136 Europe: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 137 Europe: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 138 Europe: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 139 Europe: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 140 Europe: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 141 Europe: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 142 Germany: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 143 Germany: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 144 Germany: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 145 Germany: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 146 Germany: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 147 Germany: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 148 Germany: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 149 Germany: NGS Bioinformatics Software Market, by Offering, 2022-2031 (USD Million)
  • Table 150 Germany: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 151 Germany: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 152 Germany: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 153 Germany: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 154 Germany: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 155 Germany: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 156 France: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 157 France: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 158 France: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 159 France: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 160 France: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 161 France: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 162 France: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 163 France: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 164 France: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 165 France: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 166 France: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 167 France: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 168 France: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 169 France: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 170 U.K.: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 171 U.K.: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 172 U.K.: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 173 U.K.: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 174 U.K.: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 175 U.K.: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 176 U.K.: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 177 U.K.: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 178 U.K.: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 179 U.K.: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 180 U.K.: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 181 U.K.: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 182 U.K.: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 183 U.K.: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 184 Italy: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 185 Italy: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 186 Italy: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 187 Italy: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 188 Italy: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 189 Italy: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 190 Italy: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 191 Italy: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 192 Italy: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 193 Italy: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 194 Italy: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 195 Italy: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 196 Italy: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 197 Italy: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 198 Spain: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 199 Spain: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 200 Spain: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 201 Spain: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 202 Spain: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 203 Spain: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 204 Spain: Data Analysis/Bioinformatics Market, by Type, 2022-2031 (USD Million)
  • Table 205 Spain: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 206 Spain: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 207 Spain: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 208 Spain: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 209 Spain: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 210 Spain: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 211 Spain: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 212 Roe: Estimated Number of New Cancer Cases, by Country, 2022 Vs. 2030
  • Table 213 Rest of Europe: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 214 Rest of Europe: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 215 Rest of Europe: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 216 Rest of Europe: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 217 Rest of Europe: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 218 Rest of Europe: Sequencing Systems Market, by Technology, 2022-2031 (USD Million)
  • Table 219 Rest of Europe: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 220 Rest of Europe: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 221 Rest of Europe: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 222 Rest of Europe: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 223 Rest of Europe: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 224 Rest of Europe: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 225 Rest of Europe: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 226 Rest of Europe: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 227 Asia-Pacific: NGS Market, by Country/Region, 2022-2031 (USD Million)
  • Table 228 Asia-Pacific: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 229 Asia-Pacific: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 230 Asia-Pacific: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 231 Asia-Pacific: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 232 Asia-Pacific: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 233 Asia-Pacific: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 234 Asia-Pacific: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 235 Asia-Pacific: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 236 Asia-Pacific: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 237 Asia-Pacific: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 238 Asia-Pacific: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 239 Asia-Pacific: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 240 Asia-Pacific: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 241 Asia-Pacific: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 242 China: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 243 China: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 244 China: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 245 China: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 246 China: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 247 China: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 248 China: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 249 China: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 250 China: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 251 China: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 252 China: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 253 China: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 254 China: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 255 China: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 256 Japan: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 257 Japan: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 258 Japan: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 259 Japan: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 260 Japan: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 261 Japan: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 262 Japan: Data Analysis/Bioinformatics Market, by Type, 2022-2031 (USD Million)
  • Table 263 Japan: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 264 Japan: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 265 Japan: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 266 Japan: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 267 Japan: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 268 Japan: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 269 Japan: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 270 India: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 271 India: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 272 India: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 273 India: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 274 India: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 275 India: Sequencing Systems Market, by Technology, 2022-2031 (USD Million)
  • Table 276 India: Data Analysis/Bioinformatics Market, by Type, 2022-2031 (USD Million)
  • Table 277 India: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 278 India: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 279 India: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 280 India: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 281 India: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 282 India: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 283 India: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 284 Rest of Asia-Pacific: Estimated Number of New Cancer Cases, by Country, 2022 Vs. 2030
  • Table 285 Rest of Asia-Pacific: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 286 Rest of Asia-Pacific: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 287 Rest of Asia-Pacific: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 288 Rest of Asia-Pacific: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 289 Rest of Asia-Pacific: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 290 Rest of Asia-Pacific: Sequencing Systems Market, by Technology, 2022-2031 (USD Million)
  • Table 291 Rest of Asia-Pacific: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 292 Rest of Asia-Pacific: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 293 Rest of Asia-Pacific: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 294 Rest of Asia-Pacific: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 295 Rest of Asia-Pacific: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 296 Rest of Asia-Pacific: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 297 Rest of Asia-Pacific: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 298 Rest of Asia-Pacific: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 299 Latin America: NGS Market, by Country/Region, 2022-2031 (USD Million)
  • Table 300 Latin America: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 301 Latin America: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 302 Latin America: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 303 Latin America: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 304 Latin America: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 305 Latin America: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 306 Latin America: Data Analysis/Bioinformatics Market, by Type, 2022-2031 (USD Million)
  • Table 307 Latin America: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 308 Latin America: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 309 Latin America: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 310 Latin America: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 311 Latin America: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 312 Latin America: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 313 Latin America: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 314 Brazil: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 315 Brazil: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 316 Brazil: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 317 Brazil: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 318 Brazil: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 319 Brazil: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 320 Brazil: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 321 Brazil: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 322 Brazil: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 323 Brazil: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 324 Brazil: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 325 Brazil: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 326 Brazil: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 327 Brazil: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 328 Mexico: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 329 Mexico: Sample Preparation Market, by Type, 2022-2031 (USD Million)
  • Table 330 Mexico: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 331 Mexico: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 332 Mexico: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 333 Mexico: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 334 Mexico: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 335 Mexico: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 336 Mexico: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 337 Mexico: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 338 Mexico: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 339 Mexico: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 340 Mexico: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 341 Mexico: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 342 Rest of Latin America: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 343 Rest of Latin America: Sample Preparation Market, by Type, 2022-2031 (USD Million)
  • Table 344 Rest of Latin America: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 345 Rest of Latin America: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 346 Rest of Latin America: Sequencing Market, by Type, 2022-2031 (USD Million)
  • Table 347 Rest of Latin America: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 348 Rest of Latin America: Data Analysis/Bioinformatics Market, by Type, 2022-2031 (USD Million)
  • Table 349 Rest of Latin America: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 350 Rest of Latin America: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 351 Rest of Latin America: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 352 Rest of Latin America: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 353 Rest of Latin America: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 354 Rest of Latin America: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 355 Rest of Latin America: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 356 Middle East & Africa: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 357 Middle East & Africa: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 358 Middle East & Africa: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 359 Middle East & Africa: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 360 Middle East & Africa: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 361 Middle East & Africa: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 362 Middle East & Africa: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 363 Middle East & Africa: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 364 Middle East & Africa: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 365 Middle East & Africa: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 366 Middle East & Africa: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 367 Middle East & Africa: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 368 Middle East & Africa: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 369 Middle East & Africa: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 370 Recent Developments, by Company, 2021-2024
  • Table 371 Illumina IVD Instrument Specification
  • Table 372 Illumina Informatics Options for Dx Instruments
  • Table 373 Supported IVD Assays
  • Table 374 Supported Clinical Research Panels in Ruo Mode
  • Table 375 IVD Instrument Comparison Table
  • Table 376 Key Specifications (Dx Mode)
  • Table 377 Production-Scale Sequencers Specifications
  • Table 378 Production-Scale Sequencers - Key Applications and Methods
  • Table 379 Illumina, Inc. (U.S.): NGS Systems Installed Base & New Installations In 2022
  • Table 380 Illumina, Inc. (U.S.): NGS Systems Installed Base & New Installations In 2023

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Secondary Sources Referenced for This Study
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 6 Market Sizing and Growth Forecast Approach
  • Figure 7 Global Next-Generation Sequencing Market, By Offering, 2024 Vs. 2031 (USD Million)
  • Figure 8 Global Next-Generation Sequencing Market, By Application, 2024 Vs. 2031 (USD Million)
  • Figure 9 Global Next-Generation Sequencing Market, By End User, 2024 Vs. 2031 (USD Million)
  • Figure 10 Global Next-Generation Sequencing Market, By Geography, 2024 Vs. 2031 (USD Million)
  • Figure 11 Global Pharmaceutical R&D Expenditure, 2012-2026 (USD Billion)
  • Figure 12 U.S.: Percentage of Personalized Medicine Approvals Among Total FDA Approvals, 2015-2022 (%)
  • Figure 13 Genome Sequencing Costs, 2016-2022 (USD)
  • Figure 14 USFDA Regulatory Pathways for IVD Kits
  • Figure 15 Eu Regulatory Pathway - IVDR 2017/746
  • Figure 16 China: Medical Device Classification and Pre-Market Requirements for NGS Instruments
  • Figure 17 Porter's Five Forces Analysis
  • Figure 18 Global NGS Market, By Offering, 2024 Vs 2031 (USD Million)
  • Figure 19 Steps of Sample Preparation in A Typical NGS Workflow
  • Figure 20 Global: Estimated Number of New Cancer Cases, 2022 - 2030
  • Figure 21 Global Next-Generation Sequencing (NGS) Market, By Application, 2024 Vs. 2031 (USD Million)
  • Figure 22 U.S.: New Molecular Entity (NME) Approvals, 2011-2022
  • Figure 23 Estimated Number of New Cancer Cases, 2020-2040 (In Million)
  • Figure 24 Global Next-Generation Sequencing Market, By End User, 2024 Vs. 2031 (USD Million)
  • Figure 25 Global Pharmaceutical R&D Spending, 2014-2028 (USD Billion)
  • Figure 26 NGS Market Assessment, By Region, 2024 Vs. 2031 (USD Million)
  • Figure 27 North America: Per Capita Healthcare Expenditure, 2017-2022
  • Figure 28 North America: NGS Market Snapshot
  • Figure 29 Europe: Pharmaceutical R&D Expenditure Annual Growth Rate (%)
  • Figure 30 Europe: NGS Market Snapshot
  • Figure 31 Italy: Number of Biotechnology and Biotechnology R&D-Dedicated Firms, 2014-2022
  • Figure 32 Spain Pharmaceutical R&D Expenditure, 2018-2022 (USD Million)
  • Figure 33 Rest of Europe: Pharmaceutical R&D Expenditure, 2021 (USD Million)
  • Figure 34 Asia-Pacific: NGS Market Snapshot
  • Figure 35 Japan: Pharmaceutical Industry R&D Expenditure, 2017-2022 (USD Million)
  • Figure 36 Japan: Number of New Molecular Entities Approved, 2017-2022
  • Figure 37 Latin America: NGS Market Snapshot
  • Figure 38 Number of Active Life Science Companies in Israel (2017-2022)
  • Figure 39 Key Growth Strategies Adopted by Leading Players, 2021- 2024
  • Figure 40 Next-Generation Sequencing Market: Competitive Benchmarking by Offering
  • Figure 41 Next-Generation Sequencing Market: Competitive Benchmarking, by Region
  • Figure 42 Competitive Dashboard: Next-Generation Sequencing Market
  • Figure 43 Illumina, Inc.: Financial Snapshot (2023)
  • Figure 44 Thermo Fisher Scientific Inc.: Financial Snapshot (2023)
  • Figure 45 F. Hoffmann-La Roche Ltd.: Financial Snapshot (2023)
  • Figure 46 Eurofins Scientific Se: Financial Overview (2023)
  • Figure 47 Beijing Genomics Institute (BGI): Financial Snapshot (2023)
  • Figure 48 Qiagen N.V: Financial Snapshot (2023)
  • Figure 49 Agilent Technologies, Inc.: Financial Snapshot (2023)
  • Figure 50 Revvity, Inc.: Financial Snapshot (2023)
  • Figure 51 Pacific Biosciences of California Inc.: Financial Snapshot (2023)
  • Figure 52 Danaher Corporation: Financial Snapshot (2023)
  • Figure 53 Oxford Nanopore Technologies Plc.: Financial Snapshot (2023)
  • Figure 54 Tecan Group Ltd.: Financial Snapshot (2023)
  • Figure 55 LGC Limited: Financial Overview (2023)
  • Figure 56 Eppendorf Ag: Financial Overview (2023)
  • Figure 57 Novogene Co., Ltd.: Financial Overview (2023)
  • Figure 58 MGI Tech Co., Ltd.: Financial Snapshot (2023)
  • Figure 59 Quest Diagnostics Incorporated: Financial Overview (2023)